All

Centogene GmbH

Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of pharmaceutical solutions and diagnostic tests for rare diseases

Read more about Centogene GmbH

The U.S. Department of the Treasury $51.6bn sale of stake in AIG

Read more about The U.S. Department of the Treasury $51.6bn sale of stake in AIG

London Stock Exchange Group $2.7bn acquisition of Frank Russell Company

Read more about London Stock Exchange Group $2.7bn acquisition of Frank Russell Company

TUI AG $11bn merger with TUI Travel Plc

Read more about TUI AG $11bn merger with TUI Travel Plc

Coventry $7.3bn sale to Aetna

Read more about Coventry $7.3bn sale to Aetna

Actavis $28bn acquisition of Forest Laboratories

Read more about Actavis $28bn acquisition of Forest Laboratories

他の言語

You are here

Centogene GmbH

The U.S. Department of the Treasury $51.6bn sale of stake in AIG

London Stock Exchange Group $2.7bn acquisition of Frank Russell Company

TUI AG $11bn merger with TUI Travel Plc

Coventry $7.3bn sale to Aetna

Actavis $28bn acquisition of Forest Laboratories

他の言語

Search form

You are here

All

Centogene GmbH

The U.S. Department of the Treasury $51.6bn sale of stake in AIG

London Stock Exchange Group $2.7bn acquisition of Frank Russell Company

TUI AG $11bn merger with TUI Travel Plc

Coventry $7.3bn sale to Aetna

Actavis $28bn acquisition of Forest Laboratories